Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
anti-Tau
Biotech
Janssen moves 1 of 2 AC Immune Alzheimer's vaccines to next step
Janssen has picked a tau vaccine from its collaboration with neurodegenerative-focused biotech AC Immune to advance into further development.
Annalee Armstrong
Nov 30, 2022 10:40am
TauRx plans Alzheimer's approval filing despite phase 3 failings
Oct 6, 2022 8:00am
J&J's Janssen aims for 'sweet spot' of Alzheimer's R&D
Aug 1, 2022 8:00am
AC Immune, Janssen Alzheimer's vaccine spurs tau antibodies
Feb 15, 2022 9:20am
Sanofi-backed Expansion nabs $80M for RNA neurodegenerative work
Sep 29, 2021 7:00am
Biogen, Ionis say Alzheimer's phase 1b drug is safe, tolerable
Jul 27, 2021 11:00am
